We 
The human spongiform encephalopathies, of which the most prevalent example is Creutzfeldt-Jakob disease, are multisystem neurological degenerative disorders characterized histopathologically by widespread neuronal vacuolar changes and by the accumulation in brain tissue of an abnormal ,-pleated amyloid form of a host-encoded protein that in some cases is deposited as microscopically visible amyloid plaques.
The familial occurrence of Creutzfeldt-Jakob disease, as well as other types of familial spongiform encephalopathy (Gerstmann-Straussler-Scheinker syndrome and fatal familial insomnia), has been invariably associated with one of several different mutations in the gene that encodes the precursor protein, of which the two most important are point mutations at codons 178 (Asp -> Asn) and 200 (Glu -* Lys) (1) . The resulting amino acid substitutions presumably alter the folding pattern of the full-length precursor protein to produce a j3pleated configuration that spontaneously polymerizes into amyloid fibrils. Also, the allelic disposition of polymorphic codon 129 (Met -+ Val) has been shown to influence the tempo and phenotypic expression of disease in families with pathogenic mutations in other codons (2) .
These observations place the spongiform encephalopathies squarely within the broad pathogenetic framework of both cerebral and systemic amyloidoses, in which different hostencoded proteins accumulate as amyloid deposits and in which mutations in the encoding gene have been linked to familial forms of illness (3) . In vitro experiments with synthetic peptides homologous to various regions of the native The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (Fig. 1A) produced similar fibrils, but these fibrils had a stronger tendency to aggregate and covered noticeably more grid area than did the 200glu preparations. A mixture of both peptides produced very abundant and large fibrillar aggregates. The appearance of the fibrils in each preparation was similar at 2 hr and 18 hr, except that in the peptide mixture, the density of aggregated fibrils was greater at 18 hr.
Peptides from the Area of Codon 178. Normal (178asp) peptide produced shorter, somewhat narrower fibrils than did the codon-200 peptides, usually 6-8 nm in width and <100 nm in length, that formed dense roundish clumps of indistinctly fibrillar material. The fibrils in the mutant (178asn) peptide solution (Fig. 1B) were morphologically similar to 178asp, but their overall quantity was noticeably greater. The normal/ mutant peptide mixture showed a pattern similar to the mutant peptide but displayed even larger amounts offibrillar material.
Peptides from the Area of Polymorphic Codon 129. Neither of the peptides 129met or 129val, alone or mixed together, produced any fibrils. Also, when mixed with the codon-178 or codon-200 peptides, neither 129-codon peptide changed the morphologic patterns of the codon-178 or codon-200 fibrils.
Congo Red Birefringence. Codon 200 peptides showed distinct green birefringence under polarized light; the birefringence was more intense in preparations containing the mutant peptide or the normal/mutant peptide mixture than in the normal peptide solution (Fig. 2A) . Codon 178 peptides were all less intensely birefringent than their codon-200 peptide analogs (Fig. 2B ), but the normal/mutant mixture was brighter than either individual peptide solution. No birefringence was seen in either codon-129 peptide preparation.
A semiquantitative appreciation of the EM appearance and Congo red birefringency of each peptide preparation is summarized in Table 2 .
DISCUSSION
We and others have previously shown that peptides homologous to various regions of amyloidogenic proteins form distinctive amyloid fibrils in vitro and that mutant peptides may be more fibrillogenic than their normal counterparts. The potentially important observation in this study is that mixtures of normal and mutant peptides from regions ofamyloid protein corresponding to two different pathogenic mutations linked to Creutzfeldt-Jakob disease are more fibrillogenic than either of the component peptides alone. The significance of this observation lies in the fact that the familial forms of transmissible cerebral amyloidosis are invariably associated with heterozygous mutations in this gene, resulting in heterozygosity of the encoded protein species.
Although neither of the codon-129 peptides used formed fibrils, small shifts in peptide end points or lengths can spell the difference between failure and success: for example, peptides composed of amino acids 121-136 or 129-140 do not form fibrils (13) , whereas a peptide composed of amino acids 127-147 forms excellent fibrils (14) . More with the codon-178 mutation (2), neither peptide influenced either the morphology or speed offibril formation in mixtures with the codon-178 peptides.
All fibril polymerization requires an initial nucleation, or pattern-setting association with the nucleant, followed by a phase of fibril growth, which is susceptible to steric interference by a large nucleant (an oligomer of the precursor or a heterologous or homologous microfibril). The demonstration of normal precursor molecules within amyloid deposits of mutant molecules in the genetically determined amyloidoses of familial amyloidotic polyneuropathy (20) , hereditary cerebral hemorrhage (Dutch type) (21) and the Gerstmann- (23) (24) (25) . The homologous nucleation using baby crystals of each specific morphology continues to nucleate distinct patterns of crystal growth-i.e., they breed true! Thus, we expect that our mutant polymer fibrils act in vitro as heterologous nucleants for fibril formation of the normal synthetic polymers and that the in vivo finding of normal/mutant mixtures in deposited amyloids results from the same phenomenon (3).
These in vitro peptide experiments point the way to the exploration of fibrillogenesis in cell cultures and experimental animals, which may eventually define the pathogenesis of amyloid formation in both spongiform and nonspongiform encephalopathies. However, it should not be forgotten that, in spite of their many pathogenetic similarities, the spongiform encephalopathies show one feature thus far absent from these other amyloidoses: transmissibility. Numerous primates and laboratory rodents inoculated with peptide suspensions and mixtures remain well 3 mo after inoculation, but in view of the potentially very long incubation periods in these diseases, it will be several years before a final assessment can be made.
